文献速递肾移植

帮助更多患者接受活体供肾移植

Helping More Patients Receive a Living Donor Kidney Transplant.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-08-06

本文指出活体供肾移植是许多肾衰竭患者的最佳治疗选择,成功提高活体肾捐献率的国家可减少对透析的依赖。文章概述了阻碍患者寻求活体肾捐献的障碍及潜在解决方案,并描述了在可辩护的实践体系中促进活体肾捐献的策略。安全提高活体肾捐献率需要更好的项目和政策来改善活体供者和受者的体验。

要点

  • 活体供肾移植是许多肾衰竭患者的最佳治疗选择。
  • 提高活体肾捐献率可减少对透析的依赖。
  • 需要更好的项目和政策来安全提高活体肾捐献率。

核心结论

  • 活体供肾移植是许多肾衰竭患者的最佳治疗选择,安全提高活体肾捐献率需要更好的项目和政策。

主要发现

  • 成功提高活体肾捐献率的国家将减少对透析的依赖,透析是最昂贵且高风险的肾脏替代治疗形式。

临床怎么用

  • 需要实施更好的项目和政策来改善活体供者和受者的体验,并保障活体肾捐献实践的长期安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The best treatment option for many patients with kidney failure is a kidney transplant from a living donor. Countries that successfully increase their rate of living kidney donation will decrease their reliance on dialysis, the most expensive and high-risk form of kidney replacement therapy. Outlined here are some barriers that prevent some patients from pursuing living kidney donation and current knowledge on some potential solutions to these barriers. Also described are strategies to promote living kidney donation in a defensible system of practice. Safely increasing the rate of living kidney donation will require better programs and policies to improve the experiences of living donors and their recipients, to safeguard the practice for years to come.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Garg AX. Helping More Patients Receive a Living Donor Kidney Transplant. Clin J Am Soc Nephrol. 2018. PMID: 30082336. doi:10.2215/CJN.00760118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。